Founder & Chief Executive Revolutionary
Martha Carlin is an award-winning systems thinker who is changing how we understand the links between the environment, our food and water systems, and illness. Armed with a unique ability to connect seemingly unrelated findings across diverse scientific fields to solve complex problems, her vision and guidance have built the BioCollective platform into a complete ecosystem to accelerate microbiome research and rapidly develop solutions.
Martha’s study of genetics, nutrition, biology, biochemistry, neuroscience and epigenetics began in 2002 when her husband was diagnosed with Parkinson’s Disease (PD). Martha saw the gut’s connection to chronic disease after reading Dr. Martin Blaser’s Missing Microbes in 2014, later connecting it to Dr. Filip Scheperjans’ research on the microbiome and PD She commissioned a study with the University of Chicago to investigate that connection, and the BioCollective was born, creating a patented, easy and ick-free collection kit, a sample library, and a software model to rapidly iterate unique strains and probiotics targeted to address broken functions in the human microbiome. She is a seasoned and successful executive, a sought-after speaker, and a creative problem solver who approaches systemic diseases as systemic problems that can be solved. Martha is an investor in Pure Cultures, an agricultural probiotics technology company; a Partner in PaleoBiotica, Inc.; and an advisor to the Microbiota Vault. She is the 2018 NetExplo Major Digital Talent in BioTech, a speaker at the White House Microbiome Initiative (among many others), and the 2018 Innovation Award Winner from Nutrition Business Journal.